logo

Last Update

This profile was last updated on 8/6/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Daniel Drucker?

Daniel J. Drucker

Senior Scientist

The Lunenfeld-Tanenbaum Research Institute

HQ Phone:  (416) 586-4800

Direct Phone: (416) ***-****direct phone

Email: d***@***.ca

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The Lunenfeld-Tanenbaum Research Institute

Joseph And Wolf Lebovic Centre 600 University Ave, 8Th Floor, Room 843

Toronto, Ontario,M5G 1X5

Canada

Company Description

The Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, is a leading biomedical research centre, ranking amongst the top biomedical research institutes in the world. Established in 1985, the institute is profoundly advancing understanding of h...more

Background Information

Employment History

Director

Banting & Best Diabetes Centre


Professor of Medicine

University of Toronto


Officer

Order


Affiliations

Fondation Leducq

North American Member


Receptos, Inc.

Scientific Advisory Board Member


Royal Society of Canada

Member


Amylin Pharmaceuticals , Inc.

Scientific Advisory Board Member


Versartis, Inc.

CLINICAL Advisor


Transition Therapeutics Inc.

Consultant and Advisory Board Member


Glenmark Pharmaceuticals Limited

Member, Scientific Advisory Board


Novartis AG

Consultant and Advisory Board Member


Merck & Co. , Inc.

Consultant and Advisory Board Member


GlaxoSmithKline plc

Consultant and Advisory Board Member


Eli Lilly and Company

Consultant and Advisory Board Member


ConjuChem Inc.

Consultant and Advisory Board Member


Novo Nordisk Inc

Advisor Or Consultant


Arisaph Pharmaceuticals Inc

Advisor Or Consultant


Takeda

Advisor Or Consultant


Massachusetts General Hospital

Postdoctoral Fellow


Hyphen Digital

Member of Scientific Advisory Board


School of Graduate Studies

Full Member


NPS Pharmaceuticals , Inc.

Consultant and Advisory Board Member


Triad Pharmaceutical Services LLC

Consultant and Advisory Board Member


Syrrx , Inc.

Consultant and Advisory Board Member


PPD Inc

Consultant and Advisory Board Member


Bayer AG

Consultant and Advisory Board Member


Abbott Laboratories company

Consultant and Advisory Board Member


American Society for Clinical Investigation

Active Member


Diartis Pharmaceuticals Inc

Clinical Advisor


Phenomix Corporation

Advisor Or Consultant


Education

M. D.

University of Toronto


Web References(145 Total References)


Fondation Leducq - Leadership

www.fondationleducq.org [cached]

Dr. Daniel Drucker, Lunenfeld Tanenbaum Research Institute, Toronto, Canada


www.flcq.org

Dr. Daniel Drucker, Lunenfeld Tanenbaum Research Institute, Toronto, Canada


Canada's Rare Disease Strategy Press Release | Canadian Organization for Rare Disorders

www.raredisorders.ca [cached]

Canadian researchers making important contributions to rare diseases were represented on the panel by Dr. Daniel Drucker, Senior Investigator at the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital in Toronto.
"There is a lot of interest and research being done in Canada on rare diseases but to translate the research into improved care and new therapies requires a long term coordinated approach that also links to the global research community. Implementation of Canada's Rare Disease Strategy would go a long way to helping that happen," he said.


Researchers - The Lunenfeld-Tanenbaum Research Institute

www.lunenfeld.ca [cached]

Dr. Daniel Drucker - diabetes


SLRI | Principal Investigators

user1.mshri.on.ca [cached]

Dr. Daniel Drucker
Dr. Daniel Drucker


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory